Wednesday, May 10, 2017

BRIEF-Proteon Therapeutics qtrly net loss per share attributable to common stockholders $0.39

* Proteon Therapeutics announces first quarter 2017 financial results

by reutersCOMPANYNEWS via Endless Supplies .Biz - News
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)